Bitte beachten Sie: Suchbegriffe unter einer Länge von 3 Buchstaben werden ignoriert.
917 Treffer:
11.
A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Me
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
12.
A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
13.
A Platform Study of RAS(ON) Inhibitor Combinations in Patients with RAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
14.
Eine unverblindete, multizentrische First-in-Human-Studie der Phase 1/2 zu Sicherheit, Verträglichkeit, Pharmakokinetik und Anti-Tumoraktivität von TPX-0005 bei Patienten mit fortgeschrittenen soliden Tumoren mit ALK-, ROS1- oder NTRK1-3-Rearrangements
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
15.
Beamion LUNG 2: A Phase III, Open-label, Randomized, Active-controlled, Multi-centre Trial Evaluating Orally Administered Zongertinib (BI 1810631) Compared With Standard of Care as First-line Treatment in Patients With Unresectable, Locally Advanced or Me
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
16.
DAREON™-9: A Phase Ib Open-label Dose Escalation and Dose Confirmation Safety Study of Intravenous BI 764532 in Combination With Topotecan for the Treatment of Patients With Small Cell Lung Cancer
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
17.
PHASE III STUDY COMPARING TRABECTEDIN (T) VERSUS T PLUS tTF-NGR TO ENTRAP T INSIDE THE TUMOR IN PATIENTS WITH METASTATIC AND/OR REFRACTORY SOFT TISSUE SARCOMA (STS)
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
18.
Randomized, Controlled, Open-label, Phase IIb/III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
19.
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27
20.
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
NCT Heidelberg » Ihre Suche
Datum: 2025-10-27